"Allergy & Immunology Audiology & Hearing Bariatric Surgery (Consults) Cardiothoracic Surgery (Consults) Colorectal Surgery (Consults) Dietitian (Outpatient) Endocrine Surgery (Consults) General Surgery (Consults) Infectious Disease Interventional Radiology Kidney Care Lab Services Neurology Neuropsychology Neurosurgery Orthopedic Surgery (Consults) Orthopedics & Sports Med Ostomy Care Pediatric Neurology Pediatric Orthopedics Pediatric Physiatry (PM&R) Physiatry (PM&R) Plastic & Reconstructive Surgery Podiatry Podiatric Surgery (Consults) Pulmonary Medicine Rheumatology Skin Renewal Stroke Care Transgender Care Trauma Surgery Travel Medicine Urgent Care Urologic Surgery Urology Vascular Medicine Vascular Surgery Vein Care Services"

During the past decade, Essentia Health conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 30 clinical trials were completed, i.e. on average, 176.5% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 7 clinical trials were completed. i.e. 87.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Essentia Health" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 14 trials, followed by "National Cancer Institute (NCI)" with 9 trials sponsored, "Essentia Health" with 8 trials sponsored, "HealthPartners Institute" with 4 trials sponsored and "W.L.Gore & Associates" with 4 trials sponsored. Other sponsors include 18 different institutions and companies that sponsored additional 25 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Essentia Health" #1 collaborator was "National Cancer Institute (NCI)" with 18 trials as a collaborator, "Essentia Health" with 5 trials as a collaborator, "National Institute on Aging (NIA)" with 3 trials as a collaborator, "Bristol-Myers Squibb" with 2 trials as a collaborator and "Eastern Cooperative Oncology Group" with 2 trials as a collaborator. Other collaborators include 40 different institutions and companies that were collaborators in the rest 46 trials.

According to Clinical.Site data, the most researched conditions in "Essentia Health" are "Breast Cancer" (4 trials), "Brain and Central Nervous System Tumors" (3 trials), "Recurrent Non-small Cell Lung Cancer" (3 trials), "Stage IIIB Non-small Cell Lung Cancer" (3 trials) and "Adenocarcinoma of the Prostate" (2 trials). Many other conditions were trialed in "Essentia Health" in a lesser frequency.

Most popular intervention types in "Essentia Health" are "Drug" (40 trials), "Other" (13 trials), "Biological" (8 trials), "Device" (7 trials) and "Behavioral" (4 trials). Other intervention types were less common.

The name of intervention was led by "bevacizumab" (6 trials), "carboplatin" (6 trials), "paclitaxel" (5 trials), "placebo" (5 trials) and "Placebo" (4 trials). Other intervention names were less common.

The vast majority of trials in "Essentia Health" are 52 trials for "All" genders, 7 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Essentia Health". undefined are not yet recruiting, 9 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 36 completed trials in Essentia Health, undefined suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in Essentia Health, 2 "Phase 1" clinical trials were conducted, 21 "Phase 2" clinical trials and 21 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 10 trials that are defined as “Not Applicable".